EBVMCU and oral CD30-positive lymphoproliferative disorder (CD30+ LPD) may be clinically indistinguishable and further histopathologic and immunohistochemical studies are required to obtain the definite diagnosis. This evidence concerns the gene TNFRSF8 and disseminated peritoneal leiomyomatosis.